Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 249

Results For "NSE"

2553 News Found

Wipro GE Healthcare introduces remote monitoring solution for COVID 19
Healthcare | August 04, 2021

Wipro GE Healthcare introduces remote monitoring solution for COVID 19

Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution


Mindpeers launches on-demand behavioural healthcare platform
Healthcare | August 04, 2021

Mindpeers launches on-demand behavioural healthcare platform

It is designed to tackle mental health issues


Healthium Medtech acquires SGK Lab’s AbGel gelatin business
Healthcare | August 03, 2021

Healthium Medtech acquires SGK Lab’s AbGel gelatin business

Complementary business models are the reason for the acquisition


AYUSH 64 effective in mild and moderate COVID 19
Drug Approval | August 03, 2021

AYUSH 64 effective in mild and moderate COVID 19

It works as an adjunct to standard care based on robust clinical trials


Granules India earmarks Rs 400 crore as Capex for FY 22
News | August 02, 2021

Granules India earmarks Rs 400 crore as Capex for FY 22

The company has an outlay of Rs 120-140 crore as R & D expense for FY 22


Ajanta Pharma aims to file 10-12 ANDAs per annum
News | August 02, 2021

Ajanta Pharma aims to file 10-12 ANDAs per annum

India business is growing as per projections; whereas US business will bounce back soon.


Takeda and Frazier Healthcare Partners collaborates for Norovirus vaccine candidate
Biotech | August 02, 2021

Takeda and Frazier Healthcare Partners collaborates for Norovirus vaccine candidate

Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines


Biocon Biologics partners Adagio to manufacture antibody for COVID-19
News | July 27, 2021

Biocon Biologics partners Adagio to manufacture antibody for COVID-19

ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses


Glenmark Life Sciences IPO to open on July 27, 2021
News | July 26, 2021

Glenmark Life Sciences IPO to open on July 27, 2021

The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration


Veeda Clinical Research acquires majority stake in Bioneeds
News | July 18, 2021

Veeda Clinical Research acquires majority stake in Bioneeds

Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.